Author: Samantha Budd

Biosimilar Byooviz™ Now Reimbursed In Quebec To Treat Serious Retinal Disorders

Posted by Samantha Budd | Jul 14, 2023 | Articles, News |

First provincial listing of anti-VEGF ranibizumab biosimilar brings cost-effective new option to...

Read More

A Burning Platform: Lens makers urge ECPs to embrace new technology in the fight against myopia

Posted by Samantha Budd | Jul 12, 2023 | Articles, News |

Read More

OGI Eyewear Is Proud To Officially Release Its Best-in-Class Virtual Try-On App

Posted by Samantha Budd | Jul 12, 2023 | Eyewear |

Read More

Bausch + Lomb Expands OTC Product Line with Acquisition of Blink(R) Eye Drops

Posted by Samantha Budd | Jul 12, 2023 | Articles, News |

Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to...

Read More

Poor Air Quality Caused By Wildfire Smoke Could Be Fuelling More Conjunctivitis, Eye Irritation

Posted by Samantha Budd | Jul 12, 2023 | Articles, News |

Read More

1
…
720
721
722
…
843